Read more: drreddys.com/cms/sites/defa #DrReddys #WeAreDrReddys #Semaglutide #GenericSemaglutide #DiabetesCare #GoodHealthCantWait Interesting timing after Embecta ($EMBC) CEO recently mentioned that one of their Indian GLP-1 partners received approval and launched in Canada
According to Morgan Stanley, yes
Intranasal administration can provide a direct nose-to-brain pathway via olfactory and trigeminal nerve routes, thereby reducing first-pass systemic degradation and potentially enhancing CNS exposure
Advisory committee consultation
Concluding, final evidence belongs to the consistent effect of the two distinctive regimens, given either once time daily, as intraperitoneal administration, or perorally, continuously in the drinking water (providing also the evident effect of once time initial intragastric administration), and application of the two different dose range